← Back

Multi-Disease Efficacy Testing with Standardized Biomarkers

Infrastructure and coalition to collect extra blood samples during trials and apply biomarkers for different diseases to get more value from each trial.

Resources (1)

R&D Gaps (1)

Clinical trial designs are often inefficient, resulting in high costs, lengthy timelines, and suboptimal patient outcomes. Innovative trial designs and decision-support tools are required to streamline the clinical evaluation process and accelerate therapeutic development.